BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17967977)

  • 1. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
    London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
    Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Na+ current regulation by pyridine nucleotides.
    Liu M; Sanyal S; Gao G; Gurung IS; Zhu X; Gaconnet G; Kerchner LJ; Shang LL; Huang CL; Grace A; London B; Dudley SC
    Circ Res; 2009 Oct; 105(8):737-45. PubMed ID: 19745168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome.
    Van Norstrand DW; Valdivia CR; Tester DJ; Ueda K; London B; Makielski JC; Ackerman MJ
    Circulation; 2007 Nov; 116(20):2253-9. PubMed ID: 17967976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.
    Valdivia CR; Ueda K; Ackerman MJ; Makielski JC
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1446-52. PubMed ID: 19666841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3.
    Weiss R; Barmada MM; Nguyen T; Seibel JS; Cavlovich D; Kornblit CA; Angelilli A; Villanueva F; McNamara DM; London B
    Circulation; 2002 Feb; 105(6):707-13. PubMed ID: 11839626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.
    Liu M; Liu H; Dudley SC
    Circ Res; 2010 Oct; 107(8):967-74. PubMed ID: 20724705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome.
    Morita H; Nagase S; Miura D; Miura A; Hiramatsu S; Tada T; Murakami M; Nishii N; Nakamura K; Morita ST; Oka T; Kusano KF; Ohe T
    Heart Rhythm; 2009 Apr; 6(4):487-92. PubMed ID: 19324308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
    Makita N; Mochizuki N; Tsutsui H
    Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
    Wang DW; Makita N; Kitabatake A; Balser JR; George AL
    Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
    Hu D; Barajas-Martinez H; Nesterenko VV; Pfeiffer R; Guerchicoff A; Cordeiro JM; Curtis AB; Pollevick GD; Wu Y; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):274-85. PubMed ID: 20025708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
    Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation.
    Valdivia CR; Medeiros-Domingo A; Ye B; Shen WK; Algiers TJ; Ackerman MJ; Makielski JC
    Cardiovasc Res; 2010 Jun; 86(3):392-400. PubMed ID: 20042427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.
    Frigo G; Rampazzo A; Bauce B; Pilichou K; Beffagna G; Danieli GA; Nava A; Martini B
    Europace; 2007 Jun; 9(6):391-7. PubMed ID: 17442746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
    Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M
    Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
    Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R
    Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.